Physician

Emily Pfeifer, MD

According to 2025 Medicare claims, Emily Pfeifer, MD (NPI: 1093079055) practices rheumatology in the Greeley, CO market, with the plurality of this provider's patient population coming from Weld, CO. This provider's primary affiliated billing organization is POUDRE VALLEY MEDICAL GROUP, LLC (NPI: 1366763260; TIN: 800348943) and primary practice location at 80634-5474. Pfeifer is affiliated with the Caravan Collaborative Pathways (ACO ID: A4604), Banner Network Colorado, LLC (ACO ID: A4768), Caravan Health ACO 50 LLC (ACO ID: A5160), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Pfeifer's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 172 traditional Medicare patients, billed 24,431 HCPCS/CPT codes, and received $302,056 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 1,172 prescription claims across 299 beneficiaries totaling $526,941 in drug costs, led by Methotrexate (Methotrexate Sodium). Open Payments data shows 15 records totaling $292. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $1,783 and ending at $302,056. Concurrently, Part D prescription costs have risen steadily, from $31,200 to $526,941. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	17	19	$1,783
2016	N/R	N/R	N/R
2017	20	335	$7,654
2018	71	8,056	$110,438
2019	127	21,318	$397,155
2020	163	27,504	$532,776
2021	270	22,005	$399,503
2022	282	35,747	$517,621
2023	224	13,679	$189,096
2024	172	24,431	$302,056

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	68	436	$31,200
2016	51	279	$85,814
2017	39	148	$50,739
2018	158	641	$35,908
2019	108	647	$92,429
2020	197	994	$320,198
2021	211	802	$176,898
2022	123	606	$208,023
2023	165	559	$284,563
2024	299	1,172	$526,941

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	56	64	$137
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	35	35	$125
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	102	227	$89
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	121	238	$13
96372	Injection of drug or substance under skin or into muscle	26	100	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Methotrexate	Methotrexate Sodium	250	10,844	$5,374
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	113	6,572	$4,034
Leflunomide	Leflunomide	83	4,645	$3,603
Prednisone	Prednisone	302	10,181	$2,040
Naproxen	Naproxen	19	942	$953

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	15	$292	Amgen Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Emily Pfeifer, MD?

Tedicare shows public-source Medicare data for Emily Pfeifer, MD (NPI 1093079055), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Emily Pfeifer, MD have ACO affiliation data?

Emily Pfeifer, MD is shown with ACO affiliation data for Caravan Collaborative Pathways (MSSP, ACO ID A4604), Banner Network Colorado, LLC (MSSP, ACO ID A4768), Caravan Health ACO 50 LLC (MSSP, ACO ID A5160), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Emily Pfeifer, MD?

Emily Pfeifer, MD is linked to POUDRE VALLEY MEDICAL GROUP, LLC (billing NPI 1366763260) in the available physician profile data.

Does Emily Pfeifer, MD have Open Payments data?

Emily Pfeifer, MD has 15 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.